Cited by 55Allergic Rhinitis and SensitizationAsthma and respiratory diseasesNasal Surgery and Airway Studies

Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep

Meltzer, Eli O., Munafo, Dominic A., Chung, Weiyuan, Gopalan, Gokul, Varghese, Santosh T.·2010·Annals of Allergy, Asthma & Immunology

Abstract

Background Allergic rhinitis (AR) and related nasal congestion cause rhinitis-disturbed sleep (RDS). Intranasal corticosteroids reduce nasal congestion and improve sleep quality in AR but have not been extensively studied in RDS. Objective To evaluate the efficacy of mometasone furoate nasal spray (NS) on nasal symptoms, nasal patency, sleep variables, quality of life, and daytime functioning in perennial AR (PAR) and concomitant RDS. Methods In this double-blind 4-week study, 30 adults with PAR and moderate RDS were randomized 2:1 to receive mometasone furoate NS, 200 microg, or placebo each morning. The primary end point was the apnea-hypopnea index. Secondary outcome measures included changes in total nasal symptom score (TNSS), nighttime symptom score, daytime peak nasal inspiratory flow, nighttime flow limitation index, Rhinoconjunctivitis Quality of Life Questionnaire-Standardized (RQLQ-S) score, Epworth Sleepiness Scale score, and Work Productivity and Activities Impairment-Allergy Specific (WPAI-AS) questionnaire score. Analysis of covariance was used for all efficacy end points. Results The apnea-hypopnea index at study end was not statistically significantly different between groups. However, mometasone furoate NS therapy significantly improved morning (P = .04) and evening (P = .01) TNSSs, morning (P = .049) and evening (P = .03) nasal obstruction/blockage/congestion, daily peak nasal inspiratory flow (P = .03), flow limitation index (P = .02), Epworth Sleepiness S…

Integrity signals

Registry

Crossref · 10.1016/j.anai.2010.04.020

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Effective treatment of NO can reduce the daytime sleepiness resulting from sleep disturbances in allergic rhinitis.

    “On the other hand, effective treatment of NO can reduce the daytime sleepiness resulting from sleep disturbances in AR [100].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [100]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Meltzer, E. O., Munafo, D. A., Chung, W., Gopalan, G., & Varghese, S. T.
Affiliations
  • Allergy and Asthma Medical Group and Research Center (US)
  • University of California San Diego (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Meltzer, Eli O.
Venue
Annals of Allergy, Asthma & Immunology
Publisher
Elsevier BV
Published
2010-07
Volume
105
Issue
1
Pages
65-74
ISSN
1081-1206 (ISSN-L)
OpenAlex
W2080151318
Cited by
55
References
3
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 2 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 4 · 2012: 8
FWCI
2.95
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Allergy Asthma & Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Surgery › Nasal Surgery and Airway Studies
Keywords
allergic rhinitis, mometasone furoate, intranasal corticosteroids, nasal congestion, nasal obstruction, sleep apnea, daytime sleepiness, quality of life, labor productivity, perennial allergic rhinitis
MeSH terms
Mometasone Furoate, Activities of Daily Living, Administration, Intranasal, Adolescent, Adult, Female, Humans, Male, Middle Aged, Pregnadienediols, Quality of Life, Rhinitis, Allergic, Perennial, Sleep Apnea Syndromes, Nasal Obstruction, Anti-Allergic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review